Biologically Active Small Molecules

A furanocoumarin with antibacterial activities prevents tacrine-induced cytotoxicity in HepG2 cells (EC50 = 47 &mug/ml) and vascular relaxation in phenylephrine-precontracted rat aorta weakly inhibits topoisomerase II (IC50 = 404 &muM).

A furanocoumarin with antibacterial activities prevents tacrine-induced cytotoxicity in HepG2 cells (EC50 = 47 &mug/ml) and vascular relaxation in phenylephrine-precontracted rat aorta weakly inhibits topoisomerase II (IC50 = 404 &muM).

A furanocoumarin with antibacterial activities prevents tacrine-induced cytotoxicity in HepG2 cells (EC50 = 47 &mug/ml) and vascular relaxation in phenylephrine-precontracted rat aorta weakly inhibits topoisomerase II (IC50 = 404 &muM).

An angiotensin metabolite that functions as a type 1 angiotensin II receptor agonist whereupon it can control hydroelectrolyte balance and demonstrates vasodilatory and anti-inflammatory actions in opposition to various adverse effects of

An angiotensin metabolite that functions as a type 1 angiotensin II receptor agonist whereupon it can control hydroelectrolyte balance and demonstrates vasodilatory and anti-inflammatory actions in opposition to various adverse effects of

An angiotensin metabolite that functions as a type 1 angiotensin II receptor agonist whereupon it can control hydroelectrolyte balance and demonstrates vasodilatory and anti-inflammatory actions in opposition to various adverse effects of

A peptide hormone known best as a vasoconstrictor with central roles in chronic hypertension, heart failure, and stroke.

A peptide hormone known best as a vasoconstrictor with central roles in chronic hypertension, heart failure, and stroke.

A peptide hormone known best as a vasoconstrictor with central roles in chronic hypertension, heart failure, and stroke.

A peptide hormone known best as a vasoconstrictor with central roles in chronic hypertension, heart failure, and stroke.

The angiotensin II (AII) inhibition cocktail has been developed by Bertin Pharma in order to fix physiological concentration of AII in biological samples, namely blood. Indeed, it has been observed that sample preparation is highly recommended when

The angiotensin II (AII) inhibition cocktail has been developed by Bertin Pharma in order to fix physiological concentration of AII in biological samples, namely blood. Indeed, it has been observed that sample preparation is highly recommended when